World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
63030
World Ranking
10647
National Ranking
144

Felix Mahfoud publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Felix Mahfoud sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 648 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Felix Mahfoud D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Felix Mahfoud sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Felix Mahfoud is affiliated with the University of Basel in Switzerland and is an active researcher in the field of medicine, with a primary focus on cardiology and cardiovascular medicine. Their body of work encompasses several key subfields including surgery, pulmonary and respiratory medicine, endocrinology, diabetes and metabolism, as well as radiology, nuclear medicine, and imaging.

Their research topics mainly concentrate on blood pressure and hypertension studies, heart rate variability and autonomic control, atrial fibrillation management and outcomes, cardiac arrhythmias and treatments, cardiovascular health and disease prevention, sodium intake and health, and hemodynamic monitoring and therapy.

Felix Mahfoud has contributed to numerous publications in reputable academic journals. Frequent publication venues include:

  • Journal of the American College of Cardiology
  • Journal of Hypertension
  • European Heart Journal
  • Clinical Research in Cardiology
  • Hypertension

Several recent papers by Felix Mahfoud and collaborators exemplify their research interests:

  • 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension (2023, Journal of Hypertension)
  • Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial (2020, The Lancet)
  • Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk (2021, New England Journal of Medicine)
  • Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial (2021, The Lancet)
  • Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial (2022, The Lancet)

Frequent collaborators in their research include:

  • Michael Böhm
  • Lucas Lauder
  • Roland E. Schmieder
  • David E. Kandzari
  • Michael A. Weber

Their research emphasizes interventions and clinical trials related to hypertension treatment and cardiovascular outcomes, reflecting an interdisciplinary approach that integrates clinical cardiology, therapeutic innovation, and comprehensive cardiovascular risk management.

Best Publications

  • 2018 ESC/ESH Guidelines for the management of arterial hypertension.

    Williams B;Mancia G;Spiering W;Agabiti Rosei E

  • 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

    Juhani Knuuti;William Wijns;Antti Saraste;Davide Capodanno

  • Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial

    Murray D. Esler;Henry Krum;Paul A. Sobotka;Markus P. Schlaich

  • 2018 ESC/ESH Guidelines for the management of arterial hypertension : The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

    Bryan Williams;Giuseppe Mancia;Wilko Spiering;Enrico Agabiti Rosei

  • Update on myocarditis.

    Ingrid Kindermann;Christine Barth;Felix Mahfoud;Christian Ukena

  • Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension A Pilot Study

    Felix Mahfoud;Markus Schlaich;Ingrid Kindermann;Christian Ukena

  • Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

    David E Kandzari;Michael Böhm;Felix Mahfoud;Felix Mahfoud;Raymond R Townsend

  • Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

    Raymond R Townsend;Felix Mahfoud;Felix Mahfoud;David E Kandzari;Kazuomi Kario

  • Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study

    Henry Krum;Markus P Schlaich;Paul A Sobotka;Michael Böhm

  • Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension

    Mathias C. Brandt;Felix Mahfoud;Sara Reda;Sara Reda;Stephan H. Schirmer

  • Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

    Michel Azizi;Michel Azizi;Roland E Schmieder;Felix Mahfoud;Felix Mahfoud;Michael A Weber

  • 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension

    Bryan Williams;Giuseppe Mancia;Wilko Spiering;Enrico Agabiti Rosei

  • Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension

    Felix Mahfoud;Bodo Cremers;Julia Janker;Britta Link

  • Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

    Michael Böhm;Kazuomi Kario;David E. Kandzari;Felix Mahfoud;Felix Mahfoud

  • Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

    Felix Mahfoud;Thomas Felix Lüscher;Bert Andersson;Iris Baumgartner

  • Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension

    Felix Mahfoud;Christian Ukena;Roland E. Schmieder;Bodo Cremers

  • Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy Differences in Complication Rate and Diagnostic Performance

    Ali Yilmaz;Ingrid Kindermann;Michael Kindermann;Felix Mahfoud

  • Renal Denervation in Moderate to Severe CKD

    Dagmara Hering;Felix Mahfoud;Antony S. Walton;Henry Krum

  • [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].

    Bryan Williams;Giuseppe Mancia;Wilko Spiering;Enrico Agabiti Rosei

  • Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.

    Marco Valgimigli;Enrico Frigoli;Dik Heg;Jan Tijssen

Frequent Co-Authors

Roland E. Schmieder
Roland E. Schmieder University of Erlangen-Nuremberg
Markus P. Schlaich
Markus P. Schlaich University of Western Australia
Michael Böhm
Michael Böhm Saarland University
Ulrich Laufs
Ulrich Laufs Saarland University
Murray D. Esler
Murray D. Esler Baker IDI Heart and Diabetes Institute
Giuseppe Mancia
Giuseppe Mancia University of Milano-Bicocca
David E. Kandzari
David E. Kandzari Piedmont Atlanta Hospital
Bryan Williams
Bryan Williams University College London
Henry Krum
Henry Krum Monash University
Luis M. Ruilope
Luis M. Ruilope European University of Madrid

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medicine in the USA, there are many online degree options and career pathways that can help you enter or advance in the healthcare field. Many students begin their journey by taking medical coding and billing classes online with financial aid. These programs are ideal for those seeking administrative roles and can often be completed in a short time.

For aspiring nurses, some institutions offer admissions without difficult entrance tests. By choosing a nursing school no entrance exam requirement, you can start your nursing education without added stress or delays.

Those looking to move into management may want to consider a healthcare administration accelerated degree. These fast-paced programs are designed for working professionals or students aiming to quickly advance into leadership roles.

Registered nurses can also advance their careers and expand their scope of practice through rn to np bridge programs. These flexible online pathways help nurses earn a master’s degree and become nurse practitioners, opening doors to higher responsibilities and salaries.

Best Scientists Citing Felix Mahfoud

Trending Scientists

Recently Published Articles